Sciomics – Antibody meets microarray
Sciomics GmbH was founded in the spring of 2013 as a spin-off company of the German Cancer Research Center (DKFZ) by Dr. Christoph Schröder and Dr. Jörg Hoheisel. Since 2003, our team has gained experience with production and application of antibody microarrays as a tool for analysing complex protein samples. With this background, Sciomics is able to offer complete analysis of your samples with standardised as well as customised arrays.
Analyse your protein sets of interest
Antibody microarrays make it possible to analyse complete signalling pathways, up- or downstream elements of your protein of interest or hits from next generation sequencing for their impact on protein level. Such an analysis requires only very small sample volumes, as little as 15µL of blood plasma, for example. This facilitates a robust and multiplex analysis of plasma or tissue proteins not only from human but also from small experimental animals such as the murine samples. We offer standardised arrays or produce customised arrays for your list of targets or with your selection of antibodies.
Based on more than a decade of experience in profiling studies with antibody microarrays, we also offer a complete analysis service including protein extraction from plasma, serum, tissue or cell culture samples, sample labelling and incubation as well as the subsequent data analysis.
Identification of protein biomarker signatures
In addition to their application for profiling studies, antibody microarrays are a valuable tool for the identification or verification of potential protein biomarkers. Based on analyses using complex antibody microarrays, biomarker signatures were identified for a prognosis in bladder cancer and a diagnosis of pancreatic cancer. These are currently being validated in larger scale studies.
Contact us to learn more about the potential of complex antibody microarrays for your protein biomarker screening or verification study.